Therefore, survival comparisons were performed on tumors with more than three samples predicted as ND by TP53_PROF, and where general TP53 mutational state presents with statistically significant survival prediction distinctions: lung adenocarcinoma (LUAD) and uterus corpus endothelial carcinoma (UCEC). This evidence concerns the gene TP53 and lung adenocarcinoma.